Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients

BACKGROUND: Lipoprotein apheresis (LA) is considered as an add-on therapy for patients with familial hypercholesterolemia (FH). We aimed to analyze the data collected in the last 15 years from FH patients treated with LA, to elucidate the benefit of this procedure with respect to plasma lipids, biom...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Orphanet J Rare Dis
Main Authors: Víšek, J., Bláha, M., Bláha, V., Lášticová, M., Lánska, M., Andrýs, C., Tebbens, J. Duintjer, Igreja e Sá, Ivone Cristina, Tripská, K., Vicen, M., Najmanová, I., Nachtigal, P.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7913462/
https://ncbi.nlm.nih.gov/pubmed/33640001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-021-01749-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados